NeuroDerm Ltd. Email Format

Pharmaceutical ManufacturingCentral District, Israel51-200 Employees

NeuroDerm is a mid-sized Israeli R&D company operating at the intersection of pharmaceuticals and medical technology. It focuses on developing drug-device combination therapies for central nervous system disorders, aiming to improve patient outcomes and expand treatment options. Based in Rehovot in the Central District of Israel, the firm adopts an agile, entrepreneurial mindset within the pharmaceutical manufacturing sector.

Its work targets patients and families affected by CNS conditions, engaging with the broader healthcare ecosystem to address evolving clinical needs. It continues to advance CNS product candidates that integrate drug and device components, and in 2017 it was acquired by Mitsubishi Tanabe Pharma Corporation.

Sign up for free to view info

Company overview Employee directory